| Jan 14 2025 |
FDA Finalizes a New Definition of ‘Healthy’ for Food Labeling |
Greenberg Traurig, LLP |
| Jan 13 2025 |
The Impact of Trump’s Tariffs on the Wine Industry: Past and Future |
Sheppard, Mullin, Richter & Hampton LLP |
| Jan 13 2025 |
FDA Finalizes Lead Restrictions in Processed Foods for Babies and Young Children |
Keller and Heckman LLP |
| Jan 13 2025 |
How Will the Cannabis World Look When Marijuana Is Rescheduled? |
Bradley Arant Boult Cummings LLP |
| Jan 10 2025 |
McDermott+ Check-Up: January 10, 2025 |
McDermott Will & Schulte LLP |
| Jan 9 2025 |
Preparing for a Restaurant Financing or Sale Transaction: Considerations for 2025 |
Greenberg Traurig, LLP |
| Jan 9 2025 |
Life Science Dealmaking Trends 2025 |
Mintz |
| Jan 9 2025 |
FDA’s Fresh Take on Use of “Healthy” in Food Labeling |
McDermott Will & Schulte LLP |
| Jan 9 2025 |
FDA Releases Draft Guidance for Low-Moisture Ready-to-Eat Foods |
Keller and Heckman LLP |
| Jan 9 2025 |
This Week in 340B: December 17, 2024 – January 6, 2025 |
McDermott Will & Schulte LLP |
| Jan 9 2025 |
US Surgeon General Advises on Link Between Alcohol and Cancer, Recommends Cancer Warnings on Alcohol Labels |
ArentFox Schiff LLP |
| Jan 9 2025 |
FDA Proposes New Rule on Testing Talc-Containing Cosmetic Products |
Beveridge & Diamond PC |
| Jan 9 2025 |
Transparency Is the Best Medicine: Device Parts Don’t Justify Orange Book Listing |
McDermott Will & Schulte LLP |
| Jan 8 2025 |
FDA Releases Final Guidance on Animal Food Ingredient Consultation Process |
Keller and Heckman LLP |
| Jan 8 2025 |
It’s Been a Long Time Coming: Massachusetts Health Care Market Review 2.0 |
Mintz |
| Jan 8 2025 |
Property Insurance Coverage Pitfalls for Cannabis Businesses and Landlords |
Wilson Elser Moskowitz Edelman & Dicker LLP |
| Jan 8 2025 |
FDA Releases Draft Guidance on Plant-Based Food Labeling |
Keller and Heckman LLP |
| Jan 8 2025 |
Death Knell Sounds for PFAS-Containing Food Packaging Materials |
ArentFox Schiff LLP |
| Jan 7 2025 |
Scientific Information on Unapproved Uses of Medical Products: FDA’s Final Guidance on Firm Communication to Health Care Providers |
Foley & Lardner LLP |
| Jan 7 2025 |
California Governor Issues Executive Order Targeting Ultra-Processed Foods and Food Dyes |
Keller and Heckman LLP |
| Jan 7 2025 |
United States Prevails in USMCA Dispute on Genetically Engineered Corn |
Bergeson & Campbell, P.C. |
| Jan 7 2025 |
DOT Random Drug and Alcohol Testing Rates for 2025 |
Jackson Lewis P.C. |
| Jan 7 2025 |
FDA Issues Two Final Guidance Documents on Allergens |
Keller and Heckman LLP |
| Jan 7 2025 |
Food & Chemicals Unpacked- Episode 13: Let's Pack It Up - 2024 Packaging Year in Review [Podcast] |
Keller and Heckman LLP |
| Jan 6 2025 |
MoCRA Guidance Update for Registration and Listing of Cosmetic Product Facilities and Products |
Beveridge & Diamond PC |
| Jan 6 2025 |
Federal Circuit Emphasizes Role of Filing Dates, Reversing Obviousness-Type Double Patenting Invalidation |
Sheppard, Mullin, Richter & Hampton LLP |
| Jan 6 2025 |
New Year, Same MoCRA: FDA Cosmetic Requirements as of January 1, 2025 |
ArentFox Schiff LLP |
| Jan 6 2025 |
FY 2025 NDAA Includes Biotechnology Provisions |
Bergeson & Campbell, P.C. |
| Jan 6 2025 |
Predictions: 2025 to Be a Very Big Year in Cannabis |
Bradley Arant Boult Cummings LLP |
| Jan 6 2025 |
AI-Enabled Device Software Functions: FDA’s Final Guidance for Predetermined Change Control Plans |
Foley & Lardner LLP |
| Jan 3 2025 |
Food & Chemicals Unpacked: Let's Pack It Up - 2024 Packaging Year in Review [Podcast] |
Keller and Heckman LLP |
| Jan 3 2025 |
Federal Court Vacates APHIS GMO Movement Rule |
Keller and Heckman LLP |
| Jan 2 2025 |
APHIS Restarts Permitting and “Am I Regulated” Processes for Products of Biotechnology |
Bergeson & Campbell, P.C. |
| Jan 2 2025 |
What Food Product Companies Need to Know About the New Proposition 65 Warning Requirements |
ArentFox Schiff LLP |
| Dec 31 2024 |
FDA Issues New Cosmetics Proposed Rule: Let’s Talk About Talc |
ArentFox Schiff LLP |
